LARAINE NAPIER: Open Payments
NPI 1629694153 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 7 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $139 · 2025 $484
Food & beverage: $339Education: $145
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $145 |
| GlaxoSmithKline, LLC. | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 1 | $107 |
| Janssen Biotech, Inc. | 1 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Legend Biotech USA Inc. | 1 | $14 |
Products named: JEMPERLI, LYNOZYFIC, RYBREVANT, CASGEVY, CARVYKTI.
Industry payments across OH — which companies pay providers there.
